Usefulness of Arterial Stiffness as an Integrated Marker of Cardiovascular Risk

Grethzel Prado1, María J Forner2,3,4, Oscar Calaforra5

  • 1Emergency Department, La Fe University and Polytechnic Hospital, Valencia, Spain.

Insights

Carotid-femoral pulse wave velocity (cfPWV) effectively identifies hypertension-mediated organ damage and cardiovascular risk. Repeated cfPWV measurements and their changes predict cardiovascular complications, suggesting cfPWV as a valuable surrogate endpoint.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Biomarker Discovery

Background:

  • Hypertension (HTN) poses significant cardiovascular (CV) risks, often leading to organ damage.
  • Integrated markers are needed to assess HTN-mediated organ damage (HMOD) and predict CV risk.
  • Carotid-femoral pulse wave velocity (cfPWV) is a measure of arterial stiffness.

Purpose of the Study:

  • To evaluate cfPWV as an integrated marker for HMOD and CV risk.
  • To assess the predictive value of cfPWV, including repeated measurements, for CV complications.
  • To explore cfPWV as a potential surrogate endpoint for CV risk in hypertensive patients.

Main Methods:

  • Analysis of 1031 hypertensive patients with cfPWV measurements using SphygmoCor.
  • Development of an HMOD score including microalbuminuria, LVH, IMT, and carotid plaques.
  • Cox regression and survival analysis (Harrell's C statistic) on CV complications (AF, HF, stroke, IHD, PAD, CV death) using baseline and repeated cfPWV measurements.

Main Results:

  • A trend of higher cfPWV was observed across increasing HMOD score categories.
  • Significant correlations were found between cfPWV, age, and blood pressure levels.
  • In patients with repeated cfPWV measurements, higher baseline cfPWV, second cfPWV, and cfPWV change (delta) were associated with increased CV complications.
  • An optimal threshold of 9.10 m/s for cfPWV predicted complications, with the second measurement showing the highest predictive value (Harrell's C = 0.86).

Conclusions:

  • cfPWV is a promising integrated marker for HMOD.
  • Changes in cfPWV over time are significant predictors of cardiovascular events.
  • cfPWV may serve as a valuable surrogate endpoint for assessing CV risk in hypertensive individuals.

Related Concept Videos

Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
549
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
642
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
3.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
39